Phlecs
At Phlecs, we innovate to improve the quality of life for eczema patients.
In the Netherlands, 400,000 people suffer from eczema. Eczema causes redness, but the main symptom is itching, which can be extremely severe – and sometimes even so intense that it becomes unbearable. As a result, the quality of life of many patients is negatively affected daily.
Current treatments have limitations. They are time-consuming and can cause serious side effects such as nausea, high blood pressure, and an increased risk of infections or cancer. Consequently, approximately 80% of patients are dissatisfied with their current treatment and are actively seeking alternatives. Moreover, conventional traditional UV phototherapy is based on mercury technology that is being banned in Europe.
Fortunately, we have the solution: high-intensity medical blue light therapy!